Inthis webinar, Dr Fern Slingsby, Product Specialist – Ambr®,introduces the Ambr® 250 High Throughput Generation 2, with new features optimized for process characterization studies. The first-generation Ambr® 250 High Throughput is the industry 표준 for automated, high-throughput bioreactor process development, and the second-generation system includes key improvements to streamline late-stage process development and characterization.
Discover scalability improvements,BioPAT®Viamass(capacitance) measurement capabilities, a vision system, an updated user interface, and enhanced data integrity. Learn how these advancements boost process flexibility, meet regulatory requirements, and enable robust scale-down models.
Combined with high-throughput automation and seamless transition between scales, these features reduce risks and offer clear advantages compared to conventional benchtop bioreactors for development workflows.
What You Will Learn:
Product Specialist, Ambr
Fern Slingsby has been working for 싸토리우스 since 2018. She obtained her undergraduate degree in Molecular Biology from Queen Mary, University of London, and her PhD from the Medical Research Council (UK), University of Edinburgh. Fern has over 18 years of experience in recombinant protein production, process development, and cGMP manufacture. Her background includes roles as a project leader and program manager for biopharmaceutical development and cGMP manufacture, from pre-clinical to clinical phase I, II, and III. At 싸토리우스, Fern supports customers through incorporating high-throughput technologies into 세포주 and process development, focusing on 싸토리우스’s Ambr® technology and integrated platforms.
Please select your country so we can show you products that are available for you.
The content of our website is always available in English and partly in other languages. Choose your preferred language and we will show you the content in that language, if available.